| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4304267 | Journal of Surgical Research | 2008 | 6 Pages |
Abstract
Incorporation of cell-specific biological endpoints is challenging but feasible and should be used in clinical studies of pancreatic cancer treatment. Our pilot study suggests that perillyl alcohol may indeed have effects on biological endpoints. This study will serve as a useful template for examining cell-specific biological endpoints in the testing of future agents that are thought to induce apoptosis in pancreatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Jesus M. M.D., C. Max M.D., Ph.D., M.B.A., Howard J. M.D., Oscar W. M.D., Eric A. M.D., James A. M.D., Loehrer J. M.D., P.L. Ph.D.,